Pediatrix Medical

Q1 FY2026 EarningsFY2026 Adjusted EBITDA guidance is reaffirmed at $280M to $300M, signaling stability despite sector-wide volatility. Q2 payor mix remained unchanged and consistent with historical trends, countering negative reports from other healthcare participants. Projected FY26 net income is estimated between $152.1M and $166.7M. The company maintains its hybrid revenue cycle management transition and hospital-based growth strategy.